These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 25530140)
1. Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients. Sarioglu N; Hismiogullari AA; Erel F; Demir D; Gencer N Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):60-6. PubMed ID: 25530140 [TBL] [Abstract][Full Text] [Related]
2. The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypes. Mahrooz A; Alizadeh A; Gohari G J Neurol Sci; 2014 Mar; 338(1-2):197-202. PubMed ID: 24433930 [TBL] [Abstract][Full Text] [Related]
3. Paraoxonase activity in healthy, diabetic, and hemodialysis patients. Gbandjaba NY; Ghalim N; Hassar M; Berrougui H; Labrazi H; Taki H; Saile R; Khalil A Clin Biochem; 2012 Apr; 45(6):470-4. PubMed ID: 22285382 [TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 Activity and Phenotype Distribution in Lumbar Disc Herniation Patients. Adilay U; Gencer N; Cikrikci K; Sari MF; Abdallah EA; Guclu B Turk Neurosurg; 2024; 34(4):655-659. PubMed ID: 38874244 [TBL] [Abstract][Full Text] [Related]
6. Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans. Taravati A; Ardestani SK; Ziaee AA; Ghorbani A; Soroush MR; Faghihzadeh S; Kazemi H; Rezaei A; Hoseini H; Ghazanfari T Int Immunopharmacol; 2013 Nov; 17(3):974-9. PubMed ID: 23370296 [TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report. Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815 [TBL] [Abstract][Full Text] [Related]
8. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578 [TBL] [Abstract][Full Text] [Related]
9. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation. Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476 [TBL] [Abstract][Full Text] [Related]
10. Paraoxonase phenotype distribution in a healthy Iranian population. Sepahvand F; Shafiei M; Ghaffari SM; Rahimi-Moghaddam P; Mahmoudian M Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):104-7. PubMed ID: 17651311 [TBL] [Abstract][Full Text] [Related]
11. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population. Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130 [TBL] [Abstract][Full Text] [Related]
12. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects. Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308 [TBL] [Abstract][Full Text] [Related]
13. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients. Saeed SA; Elsharkawy M; Elsaeed K; Fooda O Hemodial Int; 2008 Oct; 12(4):471-9. PubMed ID: 19090870 [TBL] [Abstract][Full Text] [Related]
14. Paraoxonase Activity and Phenotype Distribution in Patients with Chronic Obstructive Pulmonary Disease. Sarioglu N; Bilen C; Cevik C; Gencer N Eurasian J Med; 2020 Jun; 52(2):161-165. PubMed ID: 32612424 [TBL] [Abstract][Full Text] [Related]
15. Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides. Singh S; Kumar V; Thakur S; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Ichhpujani RL; Rai A Toxicol Appl Pharmacol; 2011 Apr; 252(2):130-7. PubMed ID: 21291901 [TBL] [Abstract][Full Text] [Related]
16. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease. Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483 [TBL] [Abstract][Full Text] [Related]
17. Oxidative status and serum PON1 activity in beta-thalassemia minor. Selek S; Aslan M; Horoz M; Gur M; Erel O Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173 [TBL] [Abstract][Full Text] [Related]
18. PON1-192 phenotype and genotype assessments in 918 subjects of the Stanislas cohort study. Vincent-Viry M; Sass C; Bastien S; Aguillon D; Siest G; Visvikis S Clin Chem Lab Med; 2003 Apr; 41(4):535-40. PubMed ID: 12747599 [TBL] [Abstract][Full Text] [Related]
19. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population. Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660 [TBL] [Abstract][Full Text] [Related]